EUVIMEDEUVIMED entdecken
Crossref

Screening of Glaucoma in Patients Above 40 Years Attending OPD

Sandeep Rambhau Tathe

International Journal of Pharmaceutical Quality Assurance · 31.05.2026 · 17 (05)

DOI: 10.25258/ijpqa.17.5.24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 31.05.2026. Verfasst von Sandeep Rambhau Tathe.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Glaucoma is a chronic, progressive optic neuropathy characterized by degeneration of retinal ganglion cells and optic nerve head damage, leading to irreversible visual field loss. It is one of the leading causes of preventable blindness worldwide and is often asymptomatic in its early stages. Aims & objectives: The aim of this study was to screen patients aged above 40 years attending the OPD for early detection of glaucoma and to assess its association with various demographic factors and risk factors such as age, gender, systemic diseases, and ocular risk factors. Materials & Methods: A hospital-based observational cross-sectional study will be conducted in the Department of Ophthalmology, Kamineni Institute of Medical Sciences, Sreepuram, Narketpally, Nalgonda District, Telangana, India over a period of 1 year. The study will include a total sample size of 100 patients.

Result

Symptom status showed a statistically significant association with glaucoma (p = 0.002). Glaucoma was detected in 12 patients (28.6%) among symptomatic individuals and in 3 patients (5.2%) among asymptomatic individuals.

Conclusion

We concluded that hospital-based cross-sectional study comprising 100 patients aged above 40 years attending the ophthalmology OPD highlights the clinical and epidemiological profile of glaucoma and its associated risk factors. The findings demonstrate a statistically significant increase in glaucoma prevalence with advancing age, indicating age as a strong non-modifiable risk factor.

Zitieren

APA

Tathe, S. R. (2026). Screening of Glaucoma in Patients Above 40 Years Attending OPD. International Journal of Pharmaceutical Quality Assurance, 17(05). https://doi.org/10.25258/ijpqa.17.5.24

Vancouver

Tathe SR. Screening of Glaucoma in Patients Above 40 Years Attending OPD. International Journal of Pharmaceutical Quality Assurance. 2026;17(05). doi:10.25258/ijpqa.17.5.24

BibTeX
@article{Tathe2026,
  author = {Tathe, Sandeep Rambhau},
  title = {Screening of Glaucoma in Patients Above 40 Years Attending OPD},
  journal = {International Journal of Pharmaceutical Quality Assurance},
  year = {2026},
  volume = {17},
  number = {05},
  doi = {10.25258/ijpqa.17.5.24}
}
Kostenlos starten →